Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Change in KONE Corporation's holding of treasury shares

KONE Corporation, stock exchange release, April 28, 2017 at 2.15 p.m. EEST Change in KONE Corporation's holding of treasury shares KONE Corporation has assigned a total of 483,448 KONE class B shares to the key 57 employees of the KONE share-based incentive program as a reward payment for the 2016 earnings period. KONE Corporation has assigned a total of 2,932 KONE class B shares to the members of KONE Corporation's Board of Directors as a part of the board members' annual remuneration according to the decision of the Annual General Meeting on February 28, 2017. The handover

Diamyd Medical's CEO purchased 10 000 more shares in the Company

Diamyd Medical’s CEO Ulf Hannelius has purchased 10 000 Series B shares in Diamyd Medical. Hannelius’ holdings thus amount to 50 000 B-shares. ”I intend to subsribe for my full share in the forhtcoming rights issue”, says Ulf Hannelius, President and CEO of Diamyd Medical. “It is natural to increase my shareholding now, so I can participate also with those in the issue.” Wednesday May 3, 2017, is the last day of share trading including right to participate in the rights issue. For further information about the rights issue, see www.diamyd.com. About Diamyd MedicalDiamyd

Alligator Bioscience to present new pre-clinical data for ADC-1013 and ATOR-1015 at PEGS conference in Boston, May 4

Lund, Sweden – Alligator Bioscience AB (Nasdaq Stockholm; ATORX) announced today that it will present new pre-clinical data on the CD40 agonistic immuno-oncology antibody ADC-1013, and on the bispecific OX40 and CTLA-4 dual targeting antibody ATOR-1015, at the PEGS Third Annual Agonist Immunotherapy Targets conference in Boston.  Dr Peter Ellmark, Principal Scientist at Alligator, will give an oral presentation with the title “Tumor-Directed Immunotherapy – Tumor-Localized Immune Activation Using TNFR-SF Agonistic Antibodies” in the evening on May 4 Swedish time.Alligator’s lead programme,

Nordic Waterproofing acquires the Finnish roofing company LA-Kattohuolto

Nordic Waterproofing Holding A/S (STO: NWG.ST) has today acquired 100 percent of the shares in the Finnish roof service and maintenance company LA-Kattohuolto Oy.LA-Kattohuolto Oy, established in 2010, is specialized in roof maintenance and coating of private houses. It is located in Muurame, near Jyväskylä in central Finland, with operations in nine locations, of which five are operated by franchisees. The company has annual sales of about SEK 20 million to its two main customer segments, corporate and consumer. The current management team and their colleagues will continue to

Technical correction: Tecnotree Corporation’s short report Q1 2017 Correction Key Figures

Tecnotree Corporation Stock Exchange Release 28 April 2017 at 2pm   TECNOTREE CORPORATION SHORT REPORT 1 JAN – 31 MAR 2017 (UNAUDITED)    Tecnotree is a global provider of IT solutions for the management of services, products, customers and revenue for Communications Service Providers. Tecnotree helps customers to monetise and transform their business towards a marketplace of digital services. Together with its customers, Tecnotree empowers people to self-serve, engage and take control of their own digital life.  FIRST QUARTER – RESULT IMPROVED    [][]KEY

There are no items matching the current filter
There are no more items matching the current filter
Back to top